Abstract
Despite numerous advancements in the treatment of skull base tumors, the management
of jugular paragangliomas remains controversial and nuanced. Contemporary treatment
objectives focus not only on achieving durable tumor control but also on maximizing
post-treatment quality of life. While this philosophy places appropriate attention
on limiting cranial neuropathies, less discussed morbidities such as hearing loss
can have a profound impact on quality of life outcomes. The objective of this retrospective
review is to provide a comprehensive review of hearing outcomes following the treatment
of tympanojugular paragangliomas. A particular focus is placed on the variable audiologic
outcomes as it relates to disease pathology, extent of disease, as well as chosen
treatment modality. This review underscores the importance of considering treatment-related
effects on hearing.
Keywords
paraganglioma - glomus tympanicum - hearing outcomes - stereotactic radiosurgery
